Member Info for Wilson63

Novacyt alnov nova primerdesign microgen

Recap

Microgen primerdesign nova alnov Novacyt

Whatever way you look at it Novacyt will have a lamp test before the end of March. SNPsig validated before the end of March, verilab launched soon and another 35 mil of revenues before the end of March, anybody else feel free to add to the list that
Novacyt alnov primerdesign microgen nova
Will launch before the end of March.

#onlynovacyt

Mactrader I actually wholeheartedly agree with you it's just exasperation how the share price can be reacting in this way, oh and I've no spare capital to add frustratingly.

Vanv I'm totally confident in the company just bemused that the general markets don't seem to be, and remarkable as it is to me I feel I'm much better informed than lots of these so called institutional investors/professional investors in this space, alas I quite obviously don't know how to play the markets.

Think all the opening money went elsewhere this morning, which is surprising due to the content of the Rns. That company now has a higher market cap. Than a company in the same sector making a hundred times more sales, morale of the story is don't let anybody come on here and tell you this share can't go up, it most certainly can.

Mactrader, it's beyond me to be frank it seems to be excuse after excuse that the markets don't like a wonderful debt free, profit making, sector leading, innovating company

Didn't tfl go with a wrist band? as the unions were railing(sorry) against the spy in the cab, long time ago I may be off the Mark.

Vanv Quickdraw didn't mention Avacta?
You say research not rancour but in fairness your charging about here today taking anybody to task that says anything not aligning with your opinion, I'm afraid I'll stick with my own accurate strap line.

Held ....Holding.....Hold.

Tks to uk2day

https://twitter.com/growhydrodude1/status/1363600433034444802

And again every little helps.

https://www.khaleejtimes.com/coronavirus-pandemic/covid-dubai-health-authority-adds-2-pcr-testing-centres

Deas999 m, gggg21 was on earlier saying he believed alnov had shorts on ig,

Deas999 you are so on the money there.
People with more knowledge of the stock market are going to jump on this ig decision
and try and drive the price down, be a bigger if we get news same time as others:))

Whichever thread watch this on bioinformatics only 2.18 and it explains the basics so well then there's a load of longer ones below.

https://www.youtube.com/watch?v=K9MqyU298uE

I'm going to have a good look at all this, this afternoon and see where we fit in with all the big companies mentioned following is from the article.

Few of the prominent players operating in the digital genome industry are Agilent Technologies, Inc., Becton Dickinson, Pacific Biosciences, Perkin Elmer, Sigma Aldrich and Thermo Fisher.

Interesting indeed.

B2 good post as always and to back your post up

https://www.prnewswire.com/news-releases/digital-genome-market-value-to-hit-50-4-billion-by-2025-global-market-insights-inc-300938242.html

Ps on a lighter note before being highlighted on here recently I thought genomic sequencing was whether dopey should be first or last in line, wtfdik.

India Tks to uk2day

https://scroll.in/latest/987501/coronavirus-amid-a-surge-of-cases-centre-asks-states-to-ramp-up-testing-monitor-new-strains

Retireby40, your view pcr is finished, I think the fact of accuracy and far quicker to market, and also for example the q16/32's which improve speed significantly and lots lots more which for example if you read the last few Rns's you will know all about.

ak_gabba I'm not on telegram what did you say?

From a discussion elsewhere

Innova’s test was always intended for use by professionals due to the fact that it requires a nasopharyngeal swab (brain tickler). Therefore when used in the field by non professionals, accuracy/sensitivity falls. Avacta’s test is Lower Nasal (nose picking depth). There should be no fall in accuracy with home use or use at cinema, night club....wherever.

Can anybody scientific tell me why this would make a difference to the accuracy, I realise it's easier to do.

Kay it's actually relevant a lot of countries are currently not wanting to use lft we appear to be bucking that trend, outwith uk
Avacta appear to be targeting low and med income countries from their Rns on 8th August.

Partnership to accelerate CE marking of Avacta's SARS-CoV-2 rapid antigen test and support COVID-19 testing in low and middle income countries

P.s I dont care who wins the battle as long as we all win the war.

From the blog and in essence backing up kitzie's statement.

Another addition to our SNPsig® range is VariPLEX™, which will enable the detection of the main three variants and two biologically relevant mutations.

P.s I can't tell where the blog is revised but it does say in the title.

https://twitter.com/PrimerdesignLtd/status/1363052779326091264

Says the blog is revised , not read yet.

With regards to Avacta s test I suggest people read there Rns from the 16th of February in fact here's the relavent passage

The initial evaluation of Avacta's lateral flow rapid antigen test with clinical samples has been carried out at two sites, one in EU and one in the UK using patient samples with viral loads confirmed by PCR. 30 positive samples were tested with Ct values of 26 and below, with half of those in the range 22-26, and the lateral flow test identified 29/30 of these correctly as positive. This indicates a clinical sensitivity of 96.7% for samples with a Ct value below 26. Importantly, out of a total of 26 negative samples tested with the lateral flow device, the test correctly identified all 26 as negative, giving a clinical specificity of 100%. High specificity is critical for a lateral flow test for mass screening so that large numbers of false positives are not generated which would create a major burden on follow-on testing resources, and result in a significant socio-economic cost of unnecessarily isolating people.

So it's been tested on 30 clinical samples and they are talking of it being rolled out? Sensitivity of 96.7(innova was 96% at this stage) make your own decisions on that.